◀ Back to IL1A
IL1A — PTX4
Text-mined interactions from Literome
Marcinkiewicz et al., Immunopharmacology 2000
:
PTX also
affects the production of other cytokines such as
IL-1 , IL-6, IL-10, IL-12, and IFN-gamma
Banfi et al., J Pharmacol Exp Ther 2004
(Brain Ischemia...) :
PTX treatment did
induce a greater increase of serum tumor necrosis factor-alpha (TNF-alpha), but not of
interleukin (IL)-1beta and IL-6 induced by in vivo administration of lipopolysaccharide (LPS), which suggests a protective role for TNF-alpha
Nishida et al., J Biol Chem 2010
:
Microarray analysis revealed that
PTX increases the induction of
interleukin (IL)-1beta among cytokines
Okuda et al., Immunopharmacology 1996
(Encephalomyelitis, Autoimmune, Experimental) :
Semiquantitative reverse transcriptase-polymerase chain reaction analysis revealed that
PTX at this dose
reduced the mRNA levels for tumor necrosis factor (TNF)-alpha,
interleukin (IL)-1 beta and IL-6 in peripheral blood mononuclear cells ( PBMC ) of mice with EAE
Redondo et al., Exp Dermatol 1997
:
PTX and BC
reduced TPA induced
IL-1 alpha and beta expression
Polentarutti et al., Eur J Immunol 1998
:
PTX3 is a prototypic long
pentraxin expressed by various cell types, most prominently monocytes and endothelial cells, in
response to
interleukin-1 (IL-1) , tumor necrosis factor (TNF) and bacterial products
Schratzberger et al., Immunopharmacology 1999
:
In the present study, we investigated the
effects of the anti-inflammatory drug
pentoxifylline ( PTX ) on activation of endothelial cells for enhanced adhesion and transmigration of neutrophils by lipopolysaccharide (LPS), tumor necrosis factor-alpha (TNF),
interleukin-1 (IL-1) and granulocyte colony stimulating factor ( G-CSF )